The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Aug. 1, 7:49 AM

Slide #14. Applied Genetic Technologies Corporation Secondary Offering

Company: Applied Genetic Technologies Corporation (NASDAQ:AGTC)
Date announced: 7/24/2014
Shares Offered: 2,000,000
Date of Pricing: 7/24/2014
Price Per Share: $15.00
Secondary Offering Details: Applied Genetic Technologies Corporation (Nasdaq:AGTC) today announced the pricing of its public offering of 2,000,000 shares of its common stock at a price to the public of $15.00 per share, before underwriting discounts. All of the common stock is being offered by AGTC. In addition, AGTC has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares at the public offering price to cover over-allotments, if any. The company plans to use the net proceeds from the offering to fund preclinical investigation and Phase 1/2 trials of potential product candidates for treatment of wet AMD, to expand its manufacturing capabilities and create a pilot manufacturing group, to in-license, acquire or invest in complementary gene therapy, technologies, products or assets, and for working capital and other general corporate purposes.

Applied Genetic Technologies is engaged in proprietary gene therapy to develop products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology. Co.'s product candidates are designed to treat X-linked retinoschisis (XLRS) which is an inherited retinal disease caused by mutations in the RS1 gene; Achromatopsia (ACHM) which is an inherited retinal disease, which exists from birth and is characterized by the lack of cone photoreceptor function; and X-linked retinitis pigmentosa (XLRP) which is an inherited retinal dystrophy characterized by the progressive loss of vision, one form of which is caused by mutations in the RPGR gene.
Open the AGTC Page at The Online Investor »

Company Name:  Applied Genetic Technologies Corp
Sector:  Biotechnology
Number of ETFs Holding AGTC:  10
Total Market Value Held by ETFs:  $1.90M
Total Market Capitalization:  $229.00M
% of Market Cap. Held by ETFs:  0.83%

Open the AGTC Page at The Online Investor (in a new window) »

August 1, 2014    7:49 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.